| P2093 | author name string | Peng Zhang | |
| | Jiang Li | |
| | Xiaolan Zhang | |
| | Raman Venkataramanan | |
| | Song Li | |
| | Yichao Chen | |
| | Wenchen Zhao | |
| | Yixian Huang | |
| P2860 | cites work | Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review | Q29617388 |
| | Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers | Q33235069 |
| | Well-defined, size-tunable, multifunctional micelles for efficient paclitaxel delivery for cancer treatment | Q34029697 |
| | Concepts in Ras-directed therapy | Q34119565 |
| | Block copolymer micelles for drug delivery: design, characterization and biological significance | Q34184381 |
| | Novel Ras antagonist blocks human melanoma growth | Q34505870 |
| | The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles | Q34659759 |
| | The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the spatiotemporal localization of active Ras: a potential treatment for cancer | Q34765346 |
| | Amphiphilic block copolymers for drug delivery | Q35159923 |
| | Inhibition of Ras for Cancer Treatment: The Search Continues | Q35944601 |
| | PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers | Q36485032 |
| | Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery | Q36525361 |
| | Micellar nanocarriers: pharmaceutical perspectives | Q36655007 |
| | PEG-Farnesylthiosalicylate Conjugate as a Nanomicellar Carrier for Delivery of Paclitaxel | Q36759098 |
| | Design and Characterization of PEG-Derivatized Vitamin E as a Nanomicellar Formulation for Delivery of Paclitaxel | Q37185400 |
| | Multifunctionality of lipid-core micelles for drug delivery and tumour targeting | Q37798555 |
| | Immunomodulatory Properties of Farnesoids: The New Steroids? | Q38083787 |
| | Nanomicellar carriers for targeted delivery of anticancer agents | Q38171564 |
| | Formulation of Docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy. | Q39577426 |
| | Fabrication of cationic nanomicelle from chitosan-graft-polycaprolactone as the carrier of 7-ethyl-10-hydroxy-camptothecin | Q39756230 |
| | Amine-modified hyperbranched polyesters as non-toxic, biodegradable gene delivery systems | Q39823841 |
| | Mediating tumor targeting efficiency of nanoparticles through design | Q39864411 |
| | Membrane interactions of a constitutively active GFP-Ki-Ras 4B and their role in signaling. Evidence from lateral mobility studies. | Q40982625 |
| | Dislodgment and Accelerated Degradation of Ras | Q41061827 |
| | Farnesyl derivatives of rigid carboxylic acids-inhibitors of ras-dependent cell growth | Q41350358 |
| | PEG-Derivatized Embelin as a Dual Functional Carrier for the Delivery of Paclitaxel | Q42241738 |
| | Hypersensitivity reactions from taxol | Q44119231 |
| | Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size | Q47348224 |
| | Nanotechnology: Carrying drugs | Q48317547 |
| | Taxol-induced polymerization of purified tubulin. Mechanism of action | Q72498816 |
| | Negligible clearance of ultrafine particles retained in healthy and affected human lungs | Q83205923 |
| | Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance | Q84538071 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | micelles | Q421110 |
| | paclitaxel | Q423762 |
| P304 | page(s) | 2807-2814 | |
| P577 | publication date | 2014-07-11 | |
| P1433 | published in | Molecular Pharmaceutics | Q3011140 |
| P1476 | title | PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel | |
| P478 | volume | 11 | |